Valeria Nucera

752 total citations · 1 hit paper
19 papers, 477 citations indexed

About

Valeria Nucera is a scholar working on Rheumatology, Molecular Biology and Neurology. According to data from OpenAlex, Valeria Nucera has authored 19 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Rheumatology, 5 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in Valeria Nucera's work include Rheumatoid Arthritis Research and Therapies (8 papers), Systemic Lupus Erythematosus Research (5 papers) and Inflammasome and immune disorders (5 papers). Valeria Nucera is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (8 papers), Systemic Lupus Erythematosus Research (5 papers) and Inflammasome and immune disorders (5 papers). Valeria Nucera collaborates with scholars based in Italy, Netherlands and Spain. Valeria Nucera's co-authors include Fabiola Atzeni, Ignazio Francesco Masala, Piercarlo Sarzi‐Puttini, Valeria Giorgi, Alessandra Alciati, Michael T. Nurmohamed, Gianluca Bonitta, Zoltán Szekanecz, Călin D. Popa and James Galloway and has published in prestigious journals such as Pharmacological Research, Cytokine and Journal of Clinical Medicine.

In The Last Decade

Valeria Nucera

17 papers receiving 469 citations

Hit Papers

One year in review 2021: fibromyalgia 2021 2026 2022 2024 2021 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Valeria Nucera Italy 12 166 117 97 65 60 19 477
G. Can Türkiye 12 206 1.2× 132 1.1× 113 1.2× 115 1.8× 77 1.3× 58 545
Stefania Manganelli Italy 12 192 1.2× 111 0.9× 69 0.7× 37 0.6× 107 1.8× 19 485
Salim Dönmez Türkiye 13 135 0.8× 56 0.5× 64 0.7× 57 0.9× 49 0.8× 29 379
Rafael Mendonça da Silva Chakr Brazil 16 286 1.7× 133 1.1× 95 1.0× 29 0.4× 77 1.3× 36 586
Gilwan Kim United States 13 207 1.2× 80 0.7× 118 1.2× 48 0.7× 16 0.3× 28 447
Sara Bongiovanni Italy 10 109 0.7× 81 0.7× 60 0.6× 51 0.8× 64 1.1× 22 323
Luana Mancarella Italy 16 365 2.2× 107 0.9× 55 0.6× 52 0.8× 113 1.9× 37 605
L. Boccassini Italy 16 278 1.7× 162 1.4× 187 1.9× 53 0.8× 127 2.1× 28 673
Adeel Nasir United States 4 235 1.4× 40 0.3× 82 0.8× 37 0.6× 55 0.9× 6 428
Akın Erdal Türkiye 13 257 1.5× 66 0.6× 124 1.3× 89 1.4× 76 1.3× 30 475

Countries citing papers authored by Valeria Nucera

Since Specialization
Citations

This map shows the geographic impact of Valeria Nucera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Valeria Nucera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Valeria Nucera more than expected).

Fields of papers citing papers by Valeria Nucera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Valeria Nucera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Valeria Nucera. The network helps show where Valeria Nucera may publish in the future.

Co-authorship network of co-authors of Valeria Nucera

This figure shows the co-authorship network connecting the top 25 collaborators of Valeria Nucera. A scholar is included among the top collaborators of Valeria Nucera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Valeria Nucera. Valeria Nucera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Atzeni, Fabiola, Călin D. Popa, Valeria Nucera, & Michael T. Nurmohamed. (2022). Safety of JAK inhibitors: focus on cardiovascular and thromboembolic events. Expert Review of Clinical Immunology. 18(3). 233–244. 29 indexed citations
2.
Erre, Gian Luca, Fabio Cacciapaglia, Garifallia Sakellariou, et al.. (2022). C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis. European Journal of Internal Medicine. 104. 49–54. 28 indexed citations
3.
Atzeni, Fabiola, Ignazio Francesco Masala, Javier Rodríguez‐Carrio, et al.. (2021). The Rheumatology Drugs for COVID-19 Management: Which and When?. Journal of Clinical Medicine. 10(4). 783–783. 13 indexed citations
5.
Rodríguez‐Carrio, Javier, Valeria Nucera, Ignazio Francesco Masala, & Fabiola Atzeni. (2021). Behçet disease: From pathogenesis to novel therapeutic options. Pharmacological Research. 167. 105593–105593. 23 indexed citations
6.
Alciati, Alessandra, Valeria Nucera, Ignazio Francesco Masala, et al.. (2021). One year in review 2021: fibromyalgia. Clinical and Experimental Rheumatology. 39(3). 3–12. 130 indexed citations breakdown →
7.
Atzeni, Fabiola, et al.. (2020). Cardiovascular Consequences of Autoimmune Rheumatic Diseases. Current Vascular Pharmacology. 18(6). 566–579. 11 indexed citations
8.
Atzeni, Fabiola, Valeria Nucera, Walter Fries, et al.. (2020). Study of entheses in patients with spondyloarthritis and inflammatory bowel disease with and without fibromyalgia: The importance of ultrasonography. Joint Bone Spine. 87(5). 507–508. 2 indexed citations
9.
Atzeni, Fabiola, et al.. (2020). The effect of drugs used in rheumatology for treating SARS-CoV2 infection. Expert Opinion on Biological Therapy. 21(2). 219–228. 4 indexed citations
10.
Atzeni, Fabiola, et al.. (2020). Concerns about the safety of anti-TNF agents when treating rheumatic diseases. Expert Opinion on Drug Safety. 19(6). 695–705. 11 indexed citations
11.
Cassone, Giulia, Andreina Manfredi, Fabiola Atzeni, et al.. (2020). Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study. Journal of Clinical Medicine. 9(1). 277–277. 43 indexed citations
12.
Marino, Francesca, Salvatore D’Angelo, Ignazio Francesco Masala, et al.. (2020). Toxicological considerations in the treatment of axial spondylo-arthritis. Expert Opinion on Drug Metabolism & Toxicology. 16(8). 663–672. 2 indexed citations
13.
Atzeni, Fabiola, Valeria Nucera, James Galloway, Zoltán Szekanecz, & Michael T. Nurmohamed. (2019). Cardiovascular risk in ankylosing spondylitis and the effect of anti-TNF drugs: a narrative review. Expert Opinion on Biological Therapy. 20(5). 517–524. 36 indexed citations
14.
Atzeni, Fabiola, Valeria Nucera, Ignazio Francesco Masala, Piercarlo Sarzi‐Puttini, & Gianluca Bonitta. (2019). Il-6 Involvement in pain, fatigue and mood disorders in rheumatoid arthritis and the effects of Il-6 inhibitor sarilumab. Pharmacological Research. 149. 104402–104402. 51 indexed citations
15.
Marino, Francesca, et al.. (2019). Cancer risk and tumour necrosis factor inhibitors in patients with inflammatory arthritis. Pharmacological Research. 158. 104507–104507. 7 indexed citations
16.
Caso, Francesco, Luisa Costa, Valeria Nucera, et al.. (2018). From autoinflammation to autoimmunity: old and recent findings. Clinical Rheumatology. 37(9). 2305–2321. 35 indexed citations
17.
Atzeni, Fabiola, Rossella Talotta, Valeria Nucera, et al.. (2018). Adverse events, clinical considerations and management recommendations in rheumatoid arthritis patients treated with JAK inhibitors. Expert Review of Clinical Immunology. 14(11). 945–956. 15 indexed citations
18.
Nucera, Valeria. (2010). Sentenze pregiudiziali della Corte di Giustizia e Ordinamento tributario interno. U-PAD Unimc - Open Digital Publications (University of Macerata). 1–390. 1 indexed citations
19.
Lapolla, Annunziata, M. Sanzari, Domenico Fedele, et al.. (2005). Lymphocyte subsets and cytokines in women with gestational diabetes mellitus and their newborn. Cytokine. 31(4). 280–287. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026